Cargando…

Premorbid use of selective beta-blockers improves sepsis incidence and course: Human cohort and animal model studies

INTRODUCTION: Beta-blockers are widely prescribed to manage hypertension and cardiovascular diseases and have been suggested as an attractive therapy to improve the prognosis of sepsis. Herein, we investigated the potential benefits of premorbid selective beta-blocker use in sepsis with a real-world...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hong, Shiao-Ya, Lai, Chih-Cheng, Teng, Nai-Chi, Chen, Chao-Hsien, Hsu, Chun-Chun, Chan, Nai-Ju, Wang, Cheng-Yi, Wang, Ya-Hui, Lin, You Shuei, Chen, Likwang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151496/ https://www.ncbi.nlm.nih.gov/pubmed/37144032 http://dx.doi.org/10.3389/fmed.2023.1105894

Ejemplares similares

The association between premorbid beta blocker exposure and mortality in sepsis—a systematic review
por: Tan, Kaiquan, et al.
Publicado: (2019)

Risk of sepsis among patients with COPD treated with fixed combinations of inhaled corticosteroids and long-acting Beta2 agonists
por: Wang, Cheng-Yi, et al.
Publicado: (2019)

Correction to: The association between premorbid beta blocker exposure and mortality in sepsis—a systematic review
por: Tan, Kaiquan, et al.
Publicado: (2020)

Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
por: Huang, Yueh Lan, et al.
Publicado: (2017)

Premorbid Use of Beta-Blockers or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Patients with Acute Ischemic Stroke
por: Zeng, Yuanyuan, et al.
Publicado: (2023)

Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease
por: Wu, Vin-Cent, et al.
Publicado: (2022)

Beta-blockers in sepsis
por: Singer, Mervyn
Publicado: (2019)

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

The Impact of Sepsis on the Outcomes of COPD Patients: A Population-Based Cohort Study
por: Chen, Cheng-Hsin, et al.
Publicado: (2018)

Premorbid β1-selective (but not non-selective) β-blocker exposure reduces intensive care unit mortality among septic patients
por: Kuo, Ming-Jen, et al.
Publicado: (2021)

Hypersensitivity of Airway Reflexes Induced by Hydrogen Sulfide: Role of TRPA1 Receptors
por: Chung, Chi-Li, et al.
Publicado: (2020)

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
por: Yang, Hsi-Hsing, et al.
Publicado: (2017)

Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
por: Huang, Tsan-Ming, et al.
Publicado: (2020)

Beta-blockers reduce severe exacerbation in patients with mild chronic obstructive pulmonary disease with atrial fibrillation: a population-based cohort study
por: Lin, Shan-Ju, et al.
Publicado: (2023)

Chronic rhinosinusitis and premorbid autoimmune diseases: a population-based case–control study
por: Shih, Liang-Chun, et al.
Publicado: (2020)

Mechanism and Effect of Beta-Blockers on Pancreatic Adenocarcinoma: A Literature Review
por: Upadhyaya, Vandan D., et al.
Publicado: (2020)

The Secular Trends in the Incidence Rate and Outcomes of Out-of-Hospital Cardiac Arrest in Taiwan—A Nationwide Population-Based Study
por: Wang, Cheng-Yi, et al.
Publicado: (2015)

Unsupervised clustering identifies sub-phenotypes and reveals novel outcome predictors in patients with dialysis-requiring sepsis-associated acute kidney injury
por: Lai, Chun-Fu, et al.
Publicado: (2023)

Premorbid beta blockade in sepsis is associated with a lower risk of a lactate concentration above the lactate threshold, a retrospective cohort study
por: Schneider, Liam, et al.
Publicado: (2022)

Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery
por: Yang, Shao-Yu, et al.
Publicado: (2021)

The safety of nintedanib for the treatment of interstitial lung disease: A systematic review and meta-analysis of randomized controlled trials
por: Chen, Chao-Hsien, et al.
Publicado: (2021)

Early premorbid of children with ASD
por: Kalinina, M., et al.
Publicado: (2021)

Different Non-selective β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease
por: Wang, Cheng-Yi, et al.
Publicado: (2019)

Age-related macular degeneration and premorbid allergic diseases: a population-based case–control study
por: Shen, Yi-Chen, et al.
Publicado: (2021)

Involvement of Capsaicin-Sensitive Lung Vagal Neurons and TRPA1 Receptors in Airway Hypersensitivity Induced by 1,3-β-D-Glucan in Anesthetized Rats
por: Lin, You Shuei, et al.
Publicado: (2020)

Risk of pneumonia in patients with gastroesophageal reflux disease: A population-based cohort study
por: Hsu, Wan-Tseng, et al.
Publicado: (2017)

The dimensions of responsiveness of a health system: a Taiwanese perspective
por: Hsu, Chih-Cheng, et al.
Publicado: (2006)

Dynamic Changes in Prognosis with Elapsed Time on Ventilators among Mechanically Ventilated Patients
por: Ruan, Sheng-Yuan, et al.
Publicado: (2020)

Premorbid weight in pulmonary arterial hypertension
por: Oppegard, Laura J., et al.
Publicado: (2023)

The Association of Premorbid Metformin Exposure With Mortality and Organ Dysfunction in Sepsis: A Systematic Review and Meta-Analysis
por: Tan, Kaiquan, et al.
Publicado: (2019)

Elevated Serum Vascular Cell Adhesion Molecule-1 Is Associated with Septic Encephalopathy in Adult Community-Onset Severe Sepsis Patients
por: Su, Chih-Min, et al.
Publicado: (2014)

Beta‐blockers for hypertension
por: Wiysonge, Charles S, et al.
Publicado: (2017)

Beta Blockers and Melanoma
por: Vojvodic, Aleksandra, et al.
Publicado: (2019)

Risk of lung cancer in patients with gastro-esophageal reflux disease: a population-based cohort study
por: Hsu, Chi-Kuei, et al.
Publicado: (2016)

Risks of Pneumonia in COPD Patients with New-Onset Atrial Fibrillation
por: Wang, Ya-Hui, et al.
Publicado: (2018)

The association between COPD and outcomes of patients with advanced chronic kidney disease
por: Lai, Chih-Cheng, et al.
Publicado: (2018)

Risk of Incident Non-Valvular Atrial Fibrillation after Dialysis-Requiring Acute Kidney Injury
por: Shiao, Chih-Chung, et al.
Publicado: (2018)

90-day mortality of severe sepsis and septic shock is reduced by initiation of oral beta-blocker therapy and increased by discontinuation of a pre-existing beta-blocker treatment
por: Fuchs, C, et al.
Publicado: (2015)

The impact of peroxisome proliferator‐activated receptor‐γ activating angiotensin receptor blocker on outcomes of patients receiving immunotherapy
por: Chiang, Cho‐Han, et al.
Publicado: (2023)

An unusual toxicity with beta blocker and calcium channel blocker
por: Anand, Vijay, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5r1a5afbuleseus3g5qbsjq1sf